BioMarin Pharmaceutical, Inc. (BMRN)

56.17 -1.01 (-1.77%) USD  |  NASDAQ  |  Jan 23, 16:00
56.75 +0.58 (+1.03%) After-Hours: 18:26
More

BioMarin Pharmaceutical Current Deferred Revenue (Quarterly)

Current Deferred Revenue (Quarterly) Chart

View Current Deferred Revenue (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Quarterly) Benchmarks

View Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. --
Gilead Sciences, Inc. --
Merck & Co., Inc. --
AbbVie, Inc. --
Biogen, Inc. --